Literature DB >> 16433473

[HIV patient hospitalization during the pre and post-HAART era].

Eduardo Pérez1, Javier J Toibaro, Marcelo H Losso.   

Abstract

HIV patient hospitalization during the pre and post-HAART era. The purpose of this study was to describe and to compare the characteristics of patient admissions during two periods, one pre HAART and the other when HAART was fully available. A retrospective analysis of demographic data, ambulatory care information and hospitalization characteristics was performed. Causes of admission, outcome, mortality, length of hospitalization and type of antiretroviral therapy were analyzed. A total of 330 medical records were reviewed, corresponding to 522 admissions during both study periods: 1995-96 (n = 289) and 2001-02 (n = 233). The most frequent causes of hospitalization were AIDS defining events (period 1: 57.1%; period 2: 59.7%). Tuberculosis was the main cause of admission in both periods (23.9% and 15.5%). Criptococosis (3.5%-7.3%), Pneumocystis jiroveci pneumonia (5.9%-9.4%), and CNS toxoplasmosis (6.9 -8.6%) followed tuberculosis. Mortality did not vary significantly (13.5%-16.1%). HIV-1 infection was diagnosed at admission in 30% of cases. During 2nd period, a significant decrease in re-admission (41.6-26.8%) was observed, whereas there was an increase in the percentage of patients with previous antiretroviral treatment on admission (8%-25%). An increase in the ambulatory care clinic consultations (1995: n = 1678; 1996: n = 2512; 2001: n = 5670; 2002: n = 7074) was observed. No significant differences in the causes of admission and outcome in both periods were found. Tuberculosis is the most frequent disease that motivates hospitalization. The relation between ambulatory consultations and the amount of admissions significantly increased.

Entities:  

Mesh:

Year:  2005        PMID: 16433473

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  2 in total

Review 1.  Pneumocystis jirovecii pneumonia in developing countries.

Authors:  Y de Armas Rodríguez; G Wissmann; A L Müller; M A Pederiva; M C Brum; R L Brackmann; V Capó de Paz; E J Calderón
Journal:  Parasite       Date:  2011-08       Impact factor: 3.000

2.  Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America.

Authors:  Carina Cesar; John R Koethe; Mark J Giganti; Peter Rebeiro; Keri N Althoff; Sonia Napravnik; Angel Mayor; Beatriz Grinsztejn; Marcelo Wolff; Denis Padgett; Juan Sierra-Madero; Eduardo Gotuzzo; Timothy R Sterling; James Willig; Julie Levison; Mari Kitahata; Maria C Rodriguez-Barradas; Richard D Moore; Catherine McGowan; Bryan E Shepherd; Pedro Cahn
Journal:  J Int AIDS Soc       Date:  2016-03-18       Impact factor: 5.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.